Suppr超能文献

伴有多发性不典型腺瘤样增生的肺腺癌中结节性硬化症基因相关区域杂合性缺失。

Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.

作者信息

Suzuki K, Ogura T, Yokose T, Nagai K, Mukai K, Kodama T, Nishiwaki Y, Esumi H

机构信息

Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

出版信息

Int J Cancer. 1998 Aug 21;79(4):384-9. doi: 10.1002/(sici)1097-0215(19980821)79:4<384::aid-ijc13>3.0.co;2-5.

Abstract

To investigate the potential allelic loss of tumor suppressor gene loci in the tuberous sclerosis complex (TSC)-associated regions located on the long arm of chromosome 9 (9q) and on the short arm of chromosome 16 (16p) in human lung carcinoma, we analyzed 21 paired normal and tumor DNAs with 11 polymorphic markers on the chromosomes. All tumors were adenocarcinoma of the lung, which included 9 adenocarcinomas with associated multiple atypical adenomatous hyperplasia (AAH). A precise microdissection technique followed by polymerase chain reaction (PCR) amplification to prevent under-evaluation of loss of heterozygosity (LOH) was used. Twelve of the 21 (57%) adenocarcinomas displayed LOH on 9q. Five of the 21 adenocarcinomas (24%) showed LOH at all informative loci on 9q, whereas 7 (33%) demonstrated partial LOH on 9q34. Among these 21, 5 (24%) showed partial LOH between D9S149 and D9S150, where TSC1 is located. The incidence of associated AAH was significantly higher in adenocarcinoma harboring a partial LOH in the TSC1-associated region (p = 0.0048). Twelve of the 21 (57%) adenocarcinomas displayed LOH on 16p. No significant differences in the clinico-pathological characteristics could be discerned between adenocarcinomas with and without LOH on 16p. When combining these data, a partial LOH at TSC1- and/or TSC2-associated loci was observed more frequently in cases with well-differentiated adenocarcinoma (p = 0.086) and associated AAH (p = 0.081). In conclusion, our results suggest that the TSC-associated regions are new candidate loci for tumor suppressor genes in lung adenocarcinoma, especially when it is accompanied by multiple AAH.

摘要

为了研究人类肺癌中位于9号染色体长臂(9q)和16号染色体短臂(16p)上的结节性硬化症复合物(TSC)相关区域中肿瘤抑制基因位点的潜在等位基因缺失情况,我们用染色体上的11个多态性标记分析了21对正常和肿瘤DNA。所有肿瘤均为肺腺癌,其中包括9例伴有多发非典型腺瘤样增生(AAH)的腺癌。采用精确的显微切割技术,随后进行聚合酶链反应(PCR)扩增,以防止杂合性缺失(LOH)评估不足。21例腺癌中有12例(57%)在9q上显示出LOH。21例腺癌中有5例(24%)在9q上所有信息位点均显示出LOH,而7例(33%)在9q34上显示出部分LOH。在这21例中,5例(24%)在TSC1所在的D9S149和D9S150之间显示出部分LOH。在TSC1相关区域存在部分LOH的腺癌中,相关AAH的发生率显著更高(p = 0.0048)。21例腺癌中有12例(57%)在16p上显示出LOH。在16p上有或无LOH的腺癌之间,临床病理特征无明显差异。综合这些数据,在高分化腺癌(p = 0.086)和相关AAH(p = 0.081)的病例中,TSC1和/或TSC2相关位点的部分LOH更为常见。总之,我们的结果表明,TSC相关区域是肺腺癌中肿瘤抑制基因的新候选位点,尤其是当伴有多发AAH时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验